إعلان
إعلان

CVS

CVS logo

CVS HEALTH CORPORATION

80.09
USD
برعاية
+0.73
+0.92%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

80.22

+0.13
+0.16%

تقارير أرباح CVS

النسبة الإيجابية المفاجئة

CVS تفوق 37 من 39 آخر التقديرات.

95%

التقرير التالي

بيانات التقرير القادم
١٠ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$104.68B
/
$0.99
التغير الضمني من Q3 25 (Revenue/ EPS)
+1.76%
/
-38.13%
التغير الضمني من Q4 24 (Revenue/ EPS)
+7.14%
/
-16.81%

CVS HEALTH CORPORATION earnings per share and revenue

On ٢٩ أكتوبر ٢٠٢٥, CVS reported earnings of 1.60 USD per share (EPS) for Q3 25, beating the estimate of 1.38 USD, resulting in a 15.69% surprise. Revenue reached 102.87 مليار, compared to an expected 99.84 مليار, with a 3.04% difference. The market reacted with a -1.95% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 26 analysts forecast an EPS of 0.99 USD, with revenue projected to reach 104.68 مليار USD, implying an decrease of -38.13% EPS, and increase of 1.76% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, CVS HEALTH CORPORATION reported EPS of $1.60, beating estimates by 15.69%, and revenue of $102.87B, 3.04% above expectations.
The stock price moved down -1.95%, changed from $82.20 before the earnings release to $80.60 the day after.
The next earning report is scheduled for ١٠ فبراير ٢٠٢٦.
Based on 26 analysts, CVS HEALTH CORPORATION is expected to report EPS of $0.99 and revenue of $104.68B for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان